Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
PR Newswire
Report Store
UsernamePublicRestriction
Tags:
M & A Cancer Coronavirus COVID-19

Hologic Continues Spending Spree With $230M Tuck-In Acquisition Of Biotheranostics

  • News

Executive Summary

Hologic’s recent buy-outs put it in a strengthened growth and competitive position beyond COVID.

You may also be interested in...



Hologic Acquires Somatex Medical For $64M To Expand Breast Health Care, European Sales Presence

Hologic’s acquisition of Somatex Medical will expand its biopsy portfolio and direct channel in Germany.

Hologic Acquires Acessa To Add ProVu Fibroid Treatment

Hologic has agreed to pay $80m in cash, plus contingent payments for Acessa, a privately held developer of minimally invasive treatments for uterine fibroids.

Pandemic Leaves Medtech With $500bn In M&A Firepower

EY’s M&A Firepower report predicts very active M&A activity for medtechs in 2021, driven by diagnostics and digital health, but with some headwinds remaining.

Table

View full table

Topics

Related Companies

Tags:
M & A Cancer Coronavirus COVID-19
UsernamePublicRestriction

Register

OM004634

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By